Analyst Ratings for Intersect ENT (XENT)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 2.9 / 10 Percentile Rank: 34%
Rating Score: 2.9 / 10 Percentile Rank: 34%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
8/12/2021 | Leerink Partners | Richard Newitter | Downgrade | Market Perform (Outperform) |
28.25 (N/A) |
28.01 (28.24) |
0.82% | Details |
8/10/2021 | BTIG | Ryan Zimmerman | Downgrade | Neutral (Buy) |
N/A (N/A) |
27.37 (28.24) |
3.18% | Details |